| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2b8e2017b321a8b2a55f4c091d6b89c0 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-605 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-605 |
| filingDate |
2020-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a79e855d808142a7a73a0b875e947f9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad91ece1a39be0ad6a985101aedeb01d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6cde014c141aeafc6a426b8a1e65f9d |
| publicationDate |
2022-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2022324936-A1 |
| titleOfInvention |
Process for the manufacture of glucagon |
| abstract |
The present invention provides an improved process for the preparation of glucagon, comprising the coupling of an N-terminal tetramer fragment with a C-terminal peptide, comprising at least one pseudoproline. The process is very efficient in avoiding aggregation and obtaining the desired product in high yield and purity. |
| priorityDate |
2019-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |